Title: Pediatric Brainstem Glioma: A Review
Authors: Dr Aastha Shah, Dr U Suryanarayan, Dr Ankita Parikh, Dr Rajan Yadav
DOI: https://dx.doi.org/10.18535/jmscr/v7i4.67
Abstract
Brainstem gliomas are heterogenous group of tumors with varying biological behaviour. They share a major part in causing brain tumors related deaths in paediatric patients. A large number of trials have been done so far with the use of different radiotherapy regimes and the use of different chemotherapeutic agents with a view to improve the overall survival but no statistical significant survival impact has been attained. The median survival is generally one year[11].
Keywords: Paediatric brainstem glioma .overall survival. radiotherapy.
References
- Hargrave D, Bartels U, Bouffet E. Diffuse brainstem glioma in children: critical review of clinical trials. Lancet Oncol.2006;7(3):241–8.
- Mandell LR, Kadota R, Freeman C, et al. There is no role for hyperfractionated radiotherapy in the management of children with newly diagnosed diffuse intrinsic brainstem tumors: results of a Pediatric Oncology Group phase III trial comparing conventional vs. hyperfractionated radiotherapy. Int J Radiat Oncol Biol Phys. 1999;43:959–964. [PubMed]
- Chassot A et al. Radiotherapy with concurrent and adjuvant temozolomide in children with newly diagnosed diffuse intrinsic pontine glioma. J Neurooncol. 2012;106(2):399–407. No benefit was found from the addition of TMZ to RT for the treatment of DIPG.
- Janssens GO et al. The role of hypofractionation radiotherapy for diffuse intrinsic brainstem glioma in children: a pilot study. Int J Radiat Oncol Biol Phys. 2009;73(3):722–6.
- Freeman CR, Krischer JP, Sanford RA, Cohen ME, Burger PC, Carpio R, et al. Final results of a study of escalating doses of hyperfractionated radiotherapy in brain stem tumors in children: a Pediatric Oncology Group study. International Journal of Radiation Oncology, Biology, Physics 1993;27(2):197‐206
- Kretschmar CS, Tarbell NJ, Barnes PD, Krischer JP, Burger PC, Kun L. Pre‐irradiation chemotherapy and hyperfractionated radiation therapy 66 Gy for children with brain stem tumors. A phase II study of the pediatric oncology group, protocol 8833. Cancer 1993; 72(4):1404‐
- Ahmed S, Zaghloul MS, Eldebawy E. Hypofractionated radiotherapy for pediatric diffuse intrinsic pontine glioma (DIPG) [O128]. Pediatric Blood and Cancer 2012;59(6):1003.
- Jalali R et al. Prospective evaluation of radiotherapy with concurrent and adjuvant temozolomide in children with newly diagnosed diffuse intrinsic pontine Int J Radiat Oncol Biol Phys. 2010;77(1):113–8.
- Sharp JR et al. A multi-centre Canadian pilot study of metronomic temozolomide combined with radiotherapy for newly diagnosed paediatric brainstem glioma. Eur J Cancer. 2010;46(18):3271–9.
- Survival rates and prognostic predictors of high grade brain stem gliomas in childhood:a systematic review and meta-analysis Hadeel Hassan1,2 · Anne Pinches Susan V. Picton2 · Robert S. Phillips
- Brainstem Glioma: A Review Sean A. Grimm & Marc C. Chamberlain
- Bartels U et al. Proceedings of the diffuse intrinsic pontine glioma (DIPG) Toronto Think Tank: advancing basic and translational research and cooperation in DIPG. J Neurooncol. 2011;105 (1):119–25. This is a transcript of a meeting of DIDG experts that discusses state-of-the-art treatment and basic/translational research in the field.
- Kretschmar CS et al. Pre-irradiation chemotherapy and hyperfractionated radiation therapy 66 Gy for children with brain stem tumors. A phase II study of the Pediatric Oncology Group, protocol 8833. Cancer. 1993;72(4):1404–13.
- Sharp JR et al. A multi-centre Canadian pilot study of metronomic temozolomide combined with radiotherapy for newly diagnosed paediatric brainstem glioma. Eur J Cancer. 2010;46(18):3271–9.
- Jenkin RD et al. Brain-stem tumors in childhood: a prospective randomized trial of irradiation with and without adjuvant CCNU, VCR, and prednisone. A report of the Childrens Cancer Study Group. J Neurosurg. 1987;66(2):227–33.